In another study of 127 melanomas, eight had MAP2K1 point mutations and two had MAP2K2 point mutations [10]; these alterations were associated with constitutive ERK phosphorylation, and most co-occurred with either BRAF or NRAS mutation. The gene discussed is MAP2K1; the disease is melanoma.